Fernandez-Rodriguez, Eduado J.
Sanchez-Gomez, Celia
Fonseca-Sanchez, Emilio
Rihuete-Galve, Maria Isabel
Hernández, Juan Jesús Cruz
Funding for this research was provided by:
Bristol-Myers Squibb Canada (L1FD)
Universidad de Salamanca
Article History
Received: 1 May 2025
Accepted: 26 April 2026
First Online: 29 April 2026
Declarations
:
: The study has been approved by the Ethics Committee of the Salamanca Health Area. Informed consent will be obtained, and the protocol will adhere to the Declaration of Helsinki and current data protection regulations in Spain and the EU (LOPD 3/2018 and GDPR 2016/679). Any protocol modifications will be communicated to the Ethics Committee.
: The authors declare no competing interests.
: This study follows the SPIRIT 2013 guidelines for protocol writing and the CONSORT 2010 guidelines for reporting randomised controlled trials.